Thorac Cardiovasc Surg 2013; 61(01): 097-100
DOI: 10.1055/s-0032-1331264
Case Report
Georg Thieme Verlag KG Stuttgart · New York

Pulmonary Mass Diagnosed as Extrauterine Epithelioid Trophoblastic Tumor

Hyo Yeong Ahn
1   Department of Thoracic and Cardiovascular Surgery, Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
,
I. Hoseok
1   Department of Thoracic and Cardiovascular Surgery, Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
,
Chang Hun Lee
2   Department of Pathology, Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
,
Yeun Joo Jung
3   Department of Radiology, Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
,
Na Ri Shin
2   Department of Pathology, Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
,
Ki Hyung Kim
4   Department of Obstetrics and Gynecology, Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
,
Min Ki Lee
5   Department of Internal Medicine, Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
,
Yeong Dae Kim
1   Department of Thoracic and Cardiovascular Surgery, Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
,
Jeong Su Cho
1   Department of Thoracic and Cardiovascular Surgery, Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea
› Author Affiliations
Further Information

Publication History

23 March 2012

06 May 2012

Publication Date:
10 January 2013 (online)

Preview

Abstract

Pulmonary extrauterine epithelioid trophoblastic tumors (ETTs) are extremely rare. A 26-year-old nonsmoking woman with a history of a suspected subclinical miscarriage presented with a large mass in the right lower lobe that was confirmed to be a pulmonary extrauterine ETT using immunohistochemical stains. When a nonsmoking fertile woman presents with a pulmonary mass and an elevated serum β-human chorionic gonadotrophin in the absence of gynecologic disease, pulmonary extrauterine ETT should be considered.